The post-2008 project to make banks comparable across borders had a quieter twin for insurers. It was called the Insurance Capital Standard, and for a decade it existed mostly as a negotiating document. The International Association of Insurance Supervisors adopted the final version in December 2024. Nearly everyone then went home to build a national variant of it, or to argue about whether to build one at all.
Japan did not argue. From the fiscal year that ended 31 March 2026, its Financial Services Agency retired the old Solvency Margin Ratio and switched every insurer onto an economic-value regime it calls the Economic Solvency Ratio, or J-ICS. That makes Japan the first major economy to run the global standard for real, on live balance sheets, with named public disclosures. The first scorecard landed in company filings this spring. The insurers passed.
What actually changed
The old Solvency Margin Ratio carried a 200 percent floor. That number sounds strict, and for years critics said it was not. The SMR leaned on book values and a generous count of what qualified as capital. A firm could clear 200 percent while carrying interest-rate risk the ratio never fully priced.
The Economic Solvency Ratio replaces it with a 100 percent floor. Read quickly, that looks like a regulator halving the bar. Read properly, it is the opposite. The ESR marks both assets and liabilities to economic value. Long-dated insurance liabilities get discounted against current yields, so a move in Japanese government bond rates flows straight into the ratio. The 100 percent line is not 200 percent made easier. It is a different measurement of a harder thing: whether an insurer’s economic capital actually covers its economic risk today.
This is the design the IAIS finalised in 2024, and it is the same market-adjusted, risk-based logic that has anchored Europe’s Solvency II for years. Japan did not invent it. Japan shipped it.
The numbers
The disclosures that arrived in May 2026 were not close calls.
Tokio Marine Holdings reported an ESR of 268 percent as of 31 March 2026. Nippon Life posted 195 percent on a consolidated basis and 204 percent standalone. Dai-ichi Life came in around 220 percent, up roughly ten points on the year. Fitch confirmed that all three of the big non-life groups, MS&AD, Sompo and Tokio Marine, sat above 200 percent under the new definition. The FSA-compiled figures for 21 major life insurers showed net income of 2.54 trillion yen for the year, up from 2.29 trillion a year earlier.
Every one of those firms cleared a 100 percent floor by clearing the old 200 percent line as well, on a stricter yardstick. That is the part worth sitting with. The switch to economic value did not expose a hidden hole. It confirmed the sector had capital to spare even after its liabilities were marked honestly against rising JGB yields.
There is a fair skeptical reading, and it should be stated plainly. A lower numeric floor gives management room to run thinner if it chooses, and the ratios are now more volatile because they move with rates. A 268 percent print in a low-yield quarter is not the same cushion in a repricing one. The honest verdict is not “Japan made it easier.” It is “Japan made it truer, and the truth turned out to be fine.”
Everyone else is building a different version
Here is why the timing matters. The ICS was supposed to be one standard, so that a supervisor in Tokyo, Frankfurt or Washington could read an insurer’s capital the same way. At the exact moment of implementation, that ambition is fragmenting.
The European Union’s Solvency II review is law as Directive (EU) 2025/2, and it applies from 30 January 2027, with EIOPA having finished its guidelines mandate in July 2026. Europe is measured against ICS but runs its own instrument, and it is tilting the review toward proportionality and long-term investment rather than pure convergence. The United Kingdom went further and finalised a deliberately divergent Solvency UK. The United States declined to run the ICS at all. It kept its own Aggregation Method, which the IAIS assessed in November 2024 as capable of producing “comparable outcomes,” while noting it still needs fixes to how it treats interest-rate risk and the timing of supervisory intervention. Jurisdictional assessment of the American approach is not scheduled to start in earnest until 2027.
Line those up and the single global rule has already split into at least four dialects: Japan live and ICS-aligned, the EU applying its own version in 2027, the UK openly divergent, and the US on a parallel track it insisted on keeping. The standard built to make insurers comparable arrived, on contact with national politics, as four standards.
Why a finance professional should care
Two things follow.
The first is credibility. Japan now has something no other large market has: a full year of real, ICS-aligned solvency data that held up. When the EU switches on its review in 2027 and the US grinds through its comparability assessments, Tokyo can point to a clean set of numbers and say it did the hard version first. That is soft power in a technical forum, and technical forums are where the next decade of cross-border insurance rules gets written.
The second is what to watch, and it is not the headline ratios. It is the sensitivity underneath them. Because the ESR marks liabilities to economic value, Japanese insurer solvency is now a live function of the JGB curve. Rising long-end yields have flattered these first prints by shrinking the present value of long-dated liabilities. A sharp reversal, or a disorderly move in either direction, would show up in the ratio faster than the old SMR ever allowed. The regime Japan just passed is also the regime that will report stress soonest. That is the point of it.
For now, the record stands. The global insurance capital project spent a decade as a document nobody had to live by. Japan is the first to live by it, and the first scorecard says the design works. The more interesting question is why almost everyone else, handed the same standard, decided to run a different one.
Discussion
Sign in to join the discussion.
No comments yet. Be the first to share your thoughts.